Correction: Synergistic interactions between PLK1 and HDAC inhibitors in non-Hodgkin's lymphoma cells occur in vitro and in vivo and proceed through multiple mechanisms

Oncotarget. 2019 Sep 3;10(51):5383-5384. doi: 10.18632/oncotarget.27175.

Tri Nguyen¹, Rebecca Parker¹, Elisa Hawkins¹, Beata Holkova¹, Victor Yazbeck¹, Akhil Kolluri¹, Maciej Kmieciak², Mohamed Rahmani¹, Steven Grant^{1

3

4

5

2}

¹ Division of Hematology/Oncology, Department of Internal Medicine, Virginia Commonwealth University and the Massey Cancer Center, Richmond, VA, USA.
² Massey Cancer Center, Virginia Commonwealth University Health Sciences Center, Richmond, VA, USA.
³ Departments of Biochemistry, Virginia Commonwealth University, Richmond, VA, USA.
⁴ Departments of Pharmacology, Virginia Commonwealth University, Richmond, VA, USA.
⁵ Virginia Institute for Molecular Medicine, Virginia Commonwealth University, Richmond, VA, USA.

Abstract

[This corrects the article DOI: 10.18632/oncotarget.15649.].